EXHIBIT 16.1
December 14, 2000
United States Securities and Exchange Commission
Judiciary Plaza
450 Fifth Street, N.W.
Washington, D.C. 20549
Re: Entropin, Inc.
SEC File No. 33023693
Ladies and Gentlemen:
The undersigned Causey Demgen & Moore Inc. previously acted as independent
accountants to audit the financial statements of Entropin, Inc. (the
"Company"). We are no longer acting as independent accountants to the Company.
This letter will confirm that we have reviewed Item 4. of the Company's
Form 8-K dated December 14, 2000, captioned "CHANGES IN REGISTRANT'S
CERTIFYING ACCOUNTANT" and that we agree with the statements made therein
as they relate to us.
We hereby consent to the filing of this letter as an exhibit to the
foregoing report on Form 8-K.
Dated this 14th day of December, 2000.
Sincerely,
/s/ CAUSEY DEMGEN & MOORE INC.
4
